Trevor L. Wahlbrink
General Partner
Trevor joined Ampersand in 2012. Prior to joining Ampersand, Trevor was an Associate at middle market investment banks Morgan Keegan (now Raymond James) and Covington Associates. At Covington, Trevor focused on M&A transactions of founder-owned healthcare companies. Since joining Ampersand, Trevor has spent significant time in the outsourced pharma and medical device services industries and currently serves on the Boards of Directors of Confluent Medical, Lexington Medical, MedPharm, Phosphorex and Vantage MedTech. He previously served on the Boards of Avista Pharma Solutions, Corpus Medical, ETE Medical, iuvo Biosciences, Precision Coating and TriPharm Solutions. Trevor holds an M.S. and a B.S. in Accounting and Finance from Boston College and is a CFA Charterholder.